Similar articles

• [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].

  Buiting AM, Wijermans PW. Buiting AM, et al. Ned Tijdschr Geneeskd. 2002 Jul 27;146(30):1406-11. Ned Tijdschr Geneeskd. 2002. PMID: 12174434 Dutch.
• Prognosis in monoclonal gammopathy of undetermined significance.

  Vuckovic J, Ilic A, Knezevic N, Marinkovic M, Zemunik T, Dubravcic M. Vuckovic J, et al. Br J Haematol. 1997 Jun;97(3):649-51. doi: 10.1046/j.1365-2141.1997.1072923.x. Br J Haematol. 1997. PMID: 9207414
• [Monoclonal gammopathies of undetermined significance].

  Krizalkovicová V, Maisnar V, Pour L, Radocha J, Hájek R. Krizalkovicová V, et al. Klin Onkol. 2008;21(4):160-4. Klin Onkol. 2008. PMID: 19102222 Review. Slovak.
• Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.

  Sezer O, Heider U, Zavrski I, Possinger K. Sezer O, et al. Haematologica. 2001 Aug;86(8):837-43. Haematologica. 2001. PMID: 11522540
• [Monoclonal gammopathy of undetermined significance].

  Chaïbi P, Merlin L, Thomas C, Piette F. Chaïbi P, et al. Ann Med Interne (Paris). 2002 Nov;153(7):459-66. Ann Med Interne (Paris). 2002. PMID: 12598832 Review. French.